Department of Rehabilitation Medicine, First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Dis Markers. 2022 May 9;2022:6318721. doi: 10.1155/2022/6318721. eCollection 2022.
To analyze the role of muscle energy technique (MET) plus Neurac method in stroke patients with hemiplegia complicated by diabetes mellitus and the impact on quality of life.
From January 2021 to December 2021, 100 stroke patients with hemiplegia complicated by diabetes mellitus treated in our institution and assessed for eligibility were recruited and randomly assigned (1 : 3) via the random sampling method to either the conventional rehabilitation group or the experimental group. The patients in the experimental group were randomized (1 : 1 : 1) into either the MET group (receives MET), the Neurac group (receives Neurac), or the joint group (receives MET plus Neurac). The primary endpoint is the clinical efficacy, and the second endpoint is the quality of life.
The eligible patients had similar pretreatment Barthel index scores, Visual Analogue Scale (VAS) scores, Berg balance scale (BBS) scores, Tinetti scores, Fugl-Meyer scores, and quality of life (QoL) scores ( > 0.05). The treatment herein achieved significant improvements in Barthel index scores, VAS scores (2.71 ± 0.28), BBS scores, Tinetti scores, Fugl-Meyer scores, and QoL scores (99.67 ± 10.62), and MET plus Neurac method obtained the best results versus both the conventional rehabilitation and monotherapy of either MET or Neurac ( < 0.05).
Neurac method plus MET improves the independent mobility of stroke patients with hemiplegia and diabetes, relieves pain, enhances balance and stability, mitigates limb dysfunction, and boosts patients' quality of life, so it is worthy of clinical application.
分析肌能疗法(MET)加 Neurac 法在伴有糖尿病的中风偏瘫患者中的作用及其对生活质量的影响。
选取 2021 年 1 月至 2021 年 12 月在我院就诊的 100 例伴有糖尿病的中风偏瘫患者,根据纳入和排除标准进行评估后,采用随机抽样法将其随机分为常规康复组和实验组,每组 50 例。实验组患者再采用随机数字表法分为 MET 组(接受 MET)、Neurac 组(接受 Neurac)和联合组(接受 MET 加 Neurac),每组 17 例。主要终点是临床疗效,次要终点是生活质量。
纳入患者的基线 Barthel 指数评分、视觉模拟评分(VAS)、Berg 平衡量表(BBS)评分、Tinetti 评分、Fugl-Meyer 评分和生活质量(QoL)评分相似(>0.05)。治疗后 Barthel 指数评分、VAS 评分(2.71±0.28)、BBS 评分、Tinetti 评分、Fugl-Meyer 评分和 QoL 评分均显著改善(P<0.05),且联合组优于常规康复组和 MET 组或 Neurac 组的单药治疗(P<0.05)。
Neurac 法加 MET 可提高伴有糖尿病的中风偏瘫患者的独立移动能力,减轻疼痛,增强平衡和稳定性,减轻肢体功能障碍,提高患者的生活质量,值得临床应用。